TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
TKNO

Alpha Teknova Inc

Healthcare · Drug Manufacturers - Specialty & Generic

9.30$ +4.0% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Alpha Teknova Inc (TKNO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 96 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TKNO
Line item Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– – – 63 76 173 169 167 184 182 160 152 141 133 138 129 121 115 124 119 114 110 108 104 99 96
9.7 – – 16 26 118 111 101 92 80 70 61 50 43 51 46 39 35 46 43 40 38 37 35 32 31
-9.7 – – 3.3 14 108 98 88 76 65 50 42 30 24 32 28 22 19 6.1 3.7 3.4 3.3 3.2 5.9 4.3 6.0
9.7 – – 5.1 14 108 98 88 76 65 50 42 30 24 32 28 22 19 32 30 26 24 3.2 5.9 4.3 17
– – – 6.6 5.8 5.7 5.7 5.9 7.2 5.9 6.4 4.3 4.8 5.6 5.2 3.9 4.6 4.6 4.6 4.3 5.6 5.1 5.1 4.6 5.7 5.4
– – – 3.6 3.9 3.9 4.4 5.4 6.4 7.9 10 12 12 12 11 12 11 11 7.7 6.8 6.6 7.6 6.9 7.1 6.9 6.9
– – – – 14 18 22 30 37 66 71 71 54 70 – – – – – – – – – – – –
– – – 17 17 17 17 17 17 17 0.0 0.0 – – – – – – – – – – – – – –
– – – 20 20 19 19 19 18 18 18 18 17 17 17 14 14 14 13 13 13 13 12 12 12 11
-49 – – 11 60 24 23 23 46 49 48 52 49 46 39 39 37 36 37 36 35 34 35 35 34 33
– – – 4.0 6.1 5.9 6.2 7.7 13 12 12 11 8.7 29 8.3 8.9 7.0 7.4 9.7 11 7.0 6.5 6.9 7.5 6.9 6.9
– – – – – – – – 2.1 2.2 2.3 2.2 2.0 24 1.8 1.8 1.9 2.9 4.4 5.8 1.9 1.9 1.9 1.9 1.9 2.0
– – – 1.6 2.9 2.6 3.3 2.2 3.0 1.4 3.5 2.4 1.9 1.1 1.4 1.5 1.5 1.0 1.0 0.8 1.6 1.2 1.1 1.4 1.6 1.4
– – – – 12 12 12 12 12 17 17 22 22 – 13 13 13 12 11 9.4 13 13 13 13 13 13
49 – – 52 16 149 146 143 139 133 112 100 92 86 100 90 83 79 87 82 79 76 73 69 65 63
– – – 2.3 1.6 -0.6 -3.9 -7.5 -13 -19 -42 -55 -64 -71 -81 -92 -100 -105 -113 -119 -123 -127 -131 -136 -140 -144
3.6 3.6 3.6 4.3 26 27 28 28 28 28 28 28 28 28 30 41 41 41 45 53 53 53 54 54 54 54

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?